Jean-Marie Rakic

Title: Innovations by Jean-Marie Rakic

Introduction

Jean-Marie Rakic is a notable inventor based in Havelange, Belgium. He has made significant contributions to the field of ocular drug delivery and treatment of diseases related to pathological choroidal angiogenesis. With a total of 2 patents, his work reflects a commitment to advancing medical technology.

Latest Patents

One of his latest inventions is an eye device that provides a sustained release intraocular drug delivery system. This device comprises a polymeric matrix core mixed with at least one therapeutic agent, surrounded by a polymeric coating that is both insoluble and inert in ocular fluids. The design features a compliant annular segment shape, intended for insertion into the sulcus of both intact and pseudophakic eyes.

Another significant patent involves the use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments. This invention focuses on treating diseases linked to pathological choroidal angiogenesis, utilizing derivatives that correspond to a specific general formula.

Career Highlights

Throughout his career, Jean-Marie Rakic has worked with prominent companies in the pharmaceutical industry, including Eyed Pharma and Sanofi-Aventis. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

He has collaborated with notable professionals in his field, including Jean-Michel Foidart and Alain Badorc. These partnerships have likely enhanced his research and development efforts.

Conclusion

Jean-Marie Rakic's contributions to ocular drug delivery and treatment methodologies demonstrate his innovative spirit and dedication to improving healthcare. His patents reflect a significant advancement in medical technology, showcasing his role as a leading inventor in the field.